Literature DB >> 16145388

The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.

Mesut Remzi1, Yan Kit Fong, Michael Dobrovits, Theodore Anagnostou, Christian Seitz, Matthias Waldert, Mike Harik, Sybille Marihart, Michael Marberger, Bob Djavan.   

Abstract

PURPOSE: We conducted a trial in patients with prostate specific antigen (PSA) levels from 2 to 10 ng/ml to validate a newly developed nomogram that defines the optimal number of biopsy cores required for prostate cancer (PCa) detection based on patient age and total prostate volume (Vienna nomogram).
MATERIALS AND METHODS: A total of 502 patients underwent transrectal ultrasound guided prostate biopsy using the Vienna nomogram. These results were compared with those of a previous group of 1,051 patients who had standard octant biopsies followed by systematic repeat biopsies after 6 to 8 weeks if the initial biopsy result was negative for PCa.
RESULTS: The overall PCa detection rate using the Vienna nomogram was 36.7% compared with 22% on first and 10% on repeat biopsy in the control group. The PCa detection rate using the Vienna nomogram was superior (p=0.002) to the octant biopsy technique, and comparable to a combination of first and repeat biopsy in the control group. Multivariate analysis of the Vienna nomogram showed that only PSA and the number of cores were independent predictors of PCa detection (chi-square = 49, p <0.001). Total prostate volume, transition zone volume and age were not independent predictors of PCa detection.
CONCLUSIONS: The Vienna nomogram offers an easy tool to select the optimal number of prostate biopsy cores based on patient age and total prostate volume in PSA range 2 to 10 ng/ml. Cancer detection is significantly improved (66.4%) compared to the control group. The bias factor of larger prostate volume is eliminated by using the Vienna nomogram. Moreover, the Vienna nomogram is advantageous not only in terms of the improved PCa detection rate but also economically makes systematic repeat biopsies unnecessary.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145388     DOI: 10.1097/01.ju.0000173924.83392.cc

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  CUA guidelines on prostate biopsy methodology.

Authors:  Assaad El-Hakim; Sabri Moussa
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

2.  Best of the 2003 AUA Annual Meeting: Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003, Chicago, IL.

Authors: 
Journal:  Rev Urol       Date:  2003

3.  Pathology: the lottery of conventional prostate biopsy.

Authors:  Gerald L Andriole
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

4.  Prostate cancer screening: Canadian guidelines 2011.

Authors:  Jonathan I Izawa; Laurence Klotz; D Robert Siemens; Wassim Kassouf; Alan So; John Jordan; Michael Chetner; Alla E Iansavichene
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

5.  The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer.

Authors:  Mohamed Amine Jradi; Mohamed Dridi; Mourad Teyeb; Mokhtar Ould Sidi Mohamed; Ramzi Khiary; Samir Ghozzi; Nawfel Ben Rais
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

6.  Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies.

Authors:  Daniel Portalez; Gautier Rollin; Pierre Leandri; Benjamin Elman; Patrick Mouly; Frédéric Jonca; Bernard Malavaud
Journal:  Eur Radiol       Date:  2010-08-03       Impact factor: 5.315

7.  High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels.

Authors:  Nermina Obralic; Benjamin Kulovac
Journal:  Bosn J Basic Med Sci       Date:  2011-11       Impact factor: 3.363

8.  Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.

Authors:  Hasan Yılmaz; Ufuk Yavuz; Murat Üstüner; Seyfettin Çiftçi; Hikmet Yaşar; Bahar Müezzinoğlu; Ali Kemal Uslubaş; Özdal Dillioğlugil
Journal:  Turk J Urol       Date:  2017-07-31

9.  Robotic mechanical localization of prostate cancer correlates with magnetic resonance imaging scans.

Authors:  Tae Young Shin; Yeong Jin Kim; Sey Kiat Lim; Jung Kim; Koon Ho Rha
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

10.  Detection rate of prostate cancer on the basis of the vienna nomogram: a singapore study.

Authors:  Jin Kiat Teo; Beow Kiong Poh; Foo Cheong Ng; Yan Kit Fong
Journal:  Korean J Urol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.